# A Study to Evaluate Avastin in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer

> **NCT00109226** · PHASE2 · COMPLETED · sponsor: **Genentech, Inc.**

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Avastin (Bevacizumab)

## Key facts

- **NCT ID:** NCT00109226
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-08
- **Primary completion:** —
- **Final completion:** 2003-09
- **Target enrollment:** — (—)
- **Last updated:** 2014-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00109226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00109226, "A Study to Evaluate Avastin in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00109226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*